Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Michael Mullan
Person

Michael Mullan

Overview

Edit Overview Section
Number of Founded Organizations 2
CB Rank (Person) 264,204
Michael Mullan is the Founder and CEO of Archer Pharmaceuticals. He attended London University.

Jobs

Edit Jobs Section
Number of Current Jobs 4
Michael Mullan has 4 current jobs including Co-Founder and Executive Director at AltPep, Chief Executive Officer at BioSRQ, and Founder and CEO at Archer Pharmaceuticals.

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Health Diagnostics Companies With Fewer Than 50 Employees (Top 10K) Logo
Health Diagnostics Companies With Fewer Than 50 Employees (Top 10K)
7,322
Southern US Biotechnology Companies Logo
Southern US Biotechnology Companies
5,341
Health Diagnostics Companies With Fewer Than 10 Employees Logo
Health Diagnostics Companies With Fewer Than 10 Employees
13,505
Florida Companies With More Than $10M in Revenue (Top 10K) Logo
Florida Companies With More Than $10M in Revenue (Top 10K)
7,662
East Coast Health Diagnostics Companies Logo
East Coast Health Diagnostics Companies
14,684
Health Diagnostics Companies With More Than $10M in Revenue Logo
Health Diagnostics Companies With More Than $10M in Revenue
11,021
Florida Companies With Fewer Than 10 Employees (Top 10K) Logo
Florida Companies With Fewer Than 10 Employees (Top 10K)
4,985
Florida Health Diagnostics Companies Logo
Florida Health Diagnostics Companies
42,136
Florida Biotechnology Companies Logo
Florida Biotechnology Companies
31,678
Florida Health Care Companies (Top 10K) Logo
Florida Health Care Companies (Top 10K)
8,529

Education

Edit Education Section
Michael Mullan studied at University of London and  University of London.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 12
News•May 11, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 10, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 22, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 9, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 6, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 30, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 17, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 18, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 15, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 31, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
View All
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|